[Event Report] Second Forum: The Introduction of Cost-Effectiveness Assessment, Its Impact, and Compatibility with Other Systems (September 13, 2018)
date : 10/2/2018
Tags: Future of the Health Care System, Innovation and Sustainability
HGPI convened the Second Forum “The Introduction of Cost-Effectiveness Assessment, Its Impact, and Compatibility with Other Systems” on September 13, 2018.
Based on the issues raised at the preparatory meeting “Rebalancing Healthcare Systems: Innovation and Sustainability Series – Issues Identified from the Trial Introduction of Cost-Effectiveness Assessment” held on May 31, we identified three key themes (technical issues, issues for institutionalization, and public understanding) to be discussed in FY2018 and have been conducting a series of forums.
In this meeting, a roundtable discussion on HTA implementation was held with experts from industry, government, academia, and civil society. The discussions included policy functions required for the future implementation of Cost-Effectiveness Assessment, as well as its impact on the current healthcare and drug pricing systems.
The next forum is scheduled as follows:
- The Third Forum (November): Public Understanding
– Increasing Public Awareness and Understanding on the Impacts and Benefits of Cost-Effectiveness Assessment –
Organizer: HGPI
Participants: Policymakers, representatives from the government, academia and private sectors
Opening (Explanatory introduction)
- Ryoji Noritake (President, HGPI)
Roundtable Discussions “The Introduction of Cost-Effectiveness Assessment, Its Impact, and Compatibility with Other Systems”
Roundtable Speakers (Titles omitted, in Japanese syllabary order)
- Shunya Ikeda (Professor, Graduate School of Medicine/Public Health, International University of Health and Welfare)
- Yoshie Onishi (Director, Japan Operations, Creativ-Ceutical K.K.)
- Kosuke Kato (Managing Director, Edwards Lifesciences Limited)
- Isao Kamae (Project Professor, Graduate School of Public Policy, the University of Tokyo).
- Keiji Kono (Senior Vice President, Global Health Policy, External Affairs, Chugai Pharmaceutical Co., Ltd.)
- Shigekazu Komoto (Planning Officer, Medical Economics Division, Health Insurance Bureau, Ministry of Health, Labour and Welfare (MHLW))
- Naokazu Saito (Chief, Policy Intelligence Division, Integrated Market Access Department, Janssen Pharmaceutical K.K.)
- Hiroyuki Sakamaki (Professor, School of Management, Tokyo University of Science)
- Naomi Sakurai (President, Cancer Solutions Co., Ltd.)
- Tomoyuki Takura (Project Professor, Department of Healthcare Economics and Health Policy, Graduate School of Medicine and Faculty of Medicine, the University of Tokyo)
- Toshio Nagase (Director, Government Affairs, Gilead Science K.K.)
- Hiroshi Nakamura (Professor, Graduate School of Business Administration, Keio University)
- Yoshiyuki Majima (President, Pancreatic Cancer Action Network Japan)
Moderator
- Joji Sugawara (Associate, HGPI)
Since 2016, HGPI has conducted a series of expert meetings entitled “Rebalancing Healthcare Systems: Innovation and Sustainability” to facilitate open discussions on HTA. Throughout these meetings, we have worked to identify the issues and to provide policy recommendations. For the past activities, please refer to the “Activity Report – Special Edition on Innovation and Sustainability” (attached below).
Top Research & Recommendations Posts
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Survey Report] Survey of Japanese Nursing Professionals Regarding Climate Change and Health (Preliminary Version) (September 11, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Policy Recommendations] Achieving Equity in Multidisciplinary Pain Treatment and Support Systems for Pain Management (March 31, 2023)
- [Research Report] The Public Opinion Survey on Child-Rearing in Modern Japan (Final Report) (March 4, 2022)
- [New Report] Policy Priorities for Super-Ageing Japan: Health Innovation and Economic Growth in the COVID-19 Pandemic Era (February 24, 2021)
Featured Posts
-
2024-09-26
[Registration Open] HGPI Salon Special Edition “The 2024 U.S. Presidential Election’s Impact on Japan’s Healthcare Policies: Future Implications for U.S.-China Relations and U.S.-Japan Cooperation” (October 28, 2024)
-
2024-10-07
[Registration Open] International Dialogue “Fostering Community and Citizen-led Approaches to AMR: Lessons from Antibiotic Smart Sweden” (October 25, 2024)
-
2024-10-07
[Registration Open] Planetary Health Expert Meeting “Building the Future of Healthcare: A Vision for Sustainable and Resilient Health Systems with GGHH” (November 5, 2024)
-
2024-10-09
[Registration Open] (Webinar) The 128th HGPI Seminar “Viewing Healthcare Disparities Through the Lens of Breast Cancer Treatment” (October 29, 2024)
-
2024-10-10
[Event Report] HGPI Special Seminar Commemorating Dementia Month and World Alzheimer’s Month “Examining the Role of Industry in Creating a Dementia-Inclusive Society” (September 19, 2024)